{"href":"http://player.captivate.fm/services/oembed?url=http%3A%2F%2Fplayer.captivate.fm%2Fepisode%2F313dc5ef-5cab-4b9c-9347-2b0de3a02fc7","version":"1.0","provider_name":"Captivate.FM","provider_url":"https://www.captivate.fm","width":600,"height":200,"type":"rich","html":"<iframe style=\"width: 100%; height: 200px;\" title=\"Special Edition \u2014 Management of Hepatobiliary Cancers\" frameborder=\"0\" scrolling=\"no\" allow=\"clipboard-write\" seamless src=\"http://player.captivate.fm/episode/313dc5ef-5cab-4b9c-9347-2b0de3a02fc7\"></iframe>","title":"Special Edition \u2014 Management of Hepatobiliary Cancers","description":"\n        <p>Dr Robin \u201cKatie\u201d Kelley from the UCSF Helen Diller Family Comprehensive Cancer Center in San Francisco, California discusses recent updates from ASCO 2023 on the management of hepatobiliary cancers, moderated by Dr Neil Love.</p>\n\n<p>CME information and select publications <a href=\"http://www.ResearchToPractice.com/ASCO2023HBC/AudioInterview\" rel=\"nofollow\">here</a></p>\n      ","thumbnail_width":300,"thumbnail_height":300,"thumbnail_url":"https://artwork.captivate.fm/f2e6577a-ea09-481a-902b-54da31d33f7e/cover.jpg"}